Home
 /
Papers
 /
Neuroscience
 /
Spatial proteomics reveals prefrontal circuit diversity in socioemotional behaviour
Preprint
Open access
V1
Top 1% · Validated by QED

Spatial proteomics reveals prefrontal circuit diversity in socioemotional behaviour

Yuki Ito, Sayaka Nagamoto, Sawako Uchiyama +14 more
February 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.02.08.704617
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Neuroscience this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By showing that distinct neural projections carry unique presynaptic proteomes—and that circuit-specific BLTP2 governs fear and social memory in the mPFC→BLA pathway—this work establishes molecular identity as a defining feature of brain circuits.

QED claims analysis

Summary

Spatial proteomic profiling of medial prefrontal cortex projection pathways reveals that distinct long-range circuits possess pathway-specific presynaptic molecular architectures, and identifies BLTP2 as a projection-enriched transmembrane protein that promotes excitatory synapse formation in the mPFC-BLA pathway through Neurexin 1 recruitment, thereby controlling contextual fear memory, anxiety-related behavior, and social interaction.

See full analysis
Main Claim 1 –

ProX-ID Enables In Vivo Projection-Specific Presynaptic Proteome Profiling

Main Claim 2 –

Reciprocal mPFC–BLA Projections Have Distinct Presynaptic Proteomes

Main Claim 3 –

mPFC Output Pathways Exhibit Projection-Specific Presynaptic Protein Signatures

Supporting evidence

  • Conserved Synaptic Functions Use Pathway-Specific Molecular Assemblies Across mPFC
Main Claim 4 –

BLTP2 Enriches in mPFC–BLA Terminals at Excitatory Synapses

Supporting evidence

  • BLTP2 Preferentially Localizes to Fear-Activated mPFC–BLA Synapses

Abstract

Understanding how molecular diversity across long-range neural circuits governs brain function remains a central challenge in neuroscience. Here, we developed a projection-specific spatial proteomics approach and revealed robust presynaptic molecular divergence across six projection-defined pathways of the medial prefrontal cortex (mPFC), including efferent projections to the basolateral amygdala (BLA), nucleus accumbens (NAc), thalamus (Thal), hypothalamus (HT) and cortex (CTX), as well as the afferent projection from the BLA to the mPFC. Among these pathways, we identify BLTP2 (KIAA0100), a previously uncharacterized transmembrane protein, as highly enriched in the projection from the mPFC to the BLA. BLTP2 localizes to excitatory presynaptic terminals and is enriched at synapses that are activated during memory formation. Loss of BLTP2 impairs synaptic structure and transmission, and reduces activity-dependent remodelling, resulting in selective deficits in contextual fear memory, anxiety-related behavior, and social behavior. Mechanistically, BLTP2 promotes presynaptic assembly by recruiting Neurexin 1. These findings reveal projection-specific presynaptic molecular diversity and provide mechanistic insights into circuit-level vulnerabilities in neuropsychiatric disorders.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?